Mirabel: an integrated project for risk and cost/benefit analysis of peanut allergy.
Crépet A, Papadopoulos A, Elegbede CF, Ait-Dahmane S, Loynet C, Millet G, Van Der Brempt X, Bruyère O, Marette S, Moneret-Vautrin DA.
Crépet A, et al.
Regul Toxicol Pharmacol. 2015 Mar;71(2):178-83. doi: 10.1016/j.yrtph.2014.12.006. Epub 2014 Dec 15.
Regul Toxicol Pharmacol. 2015.
PMID: 25523940